| Literature DB >> 27314656 |
Flavia Riccardo, Martina Del Manso, Maria Grazia Caporali, Christian Napoli, Jens P Linge, Eleonora Mantica, Marco Verile, Alessandra Piatti, Maria Grazia Pompa, Loredana Vellucci, Virgilio Costanzo, Anan Judina Bastiampillai, Eugenia Gabrielli, Maria Gramegna, Silvia Declich.
Abstract
More than 21 million participants attended EXPO Milan from May to October 2015, making it one of the largest protracted mass gathering events in Europe. Given the expected national and international population movement and health security issues associated with this event, Italy fully implemented, for the first time, an event-based surveillance (EBS) system focusing on naturally occurring infectious diseases and the monitoring of biological agents with potential for intentional release. The system started its pilot phase in March 2015 and was fully operational between April and November 2015. In order to set the specific objectives of the EBS system, and its complementary role to indicator-based surveillance, we defined a list of priority diseases and conditions. This list was designed on the basis of the probability and possible public health impact of infectious disease transmission, existing statutory surveillance systems in place, and any surveillance enhancements during the mass gathering event. This article reports the methodology used to design the EBS system for EXPO Milan and the results of 8 months of surveillance.Entities:
Mesh:
Year: 2016 PMID: 27314656 PMCID: PMC4931307 DOI: 10.1089/hs.2015.0075
Source DB: PubMed Journal: Health Secur ISSN: 2326-5094
Italian Event-Based Surveillance Assessment Tool
| 0 | Impact of the event on public health | 1-4 | 1 – No impact (the event does not imply changes in public health actions) |
| 2 – Medium impact (the event stimulates nonurgent public health actions and/or actions aimed at preventing nonsevere disease in the population) | |||
| 3 – High impact (the event stimulates urgent public health actions and/or actions aimed at preventing severe disease in the population) | |||
| 4 – Very high impact (the event has a national and/or international relevance—eg, autochthonous cases of new diseases, first seasonal case of influenza) | |||
| 1 | Severity (case fatality, severity of symptoms) | 1-3 | 1 – Low impact (no case of disease or cases of mild disease) |
| 2 – Medium impact (hospitalized cases) | |||
| 3 – High impact (cases with severe disease, hospitalized in intensive care units, and/or dead) | |||
| 2 | Spread | 1-3 | 1 – Localized event/spread unknown |
| 2 – High number of cases in one region | |||
| 3 – Cases in more than one region | |||
| 3 | Is the disease endemic? Is the event described common in Italy? | 1-3 | 1 – Event describes an endemic disease in Italy, epidemiology as expected |
| 2 – Epidemiology unusual but within accepted norms/unknown disease[ | |||
| 3 – Unexpected or unusual event and/or disease nonendemic in Italy | |||
| 4 | Is clinical presentation (including outcome and response to treatment or drug resistance) as expected? | 1-3 | 1 – Clinical presentation as expected or unknown[ |
| 2 – Atypical clinical presentation but compatible with a naturally occurring disease | |||
| 3 – Very unusual clinical presentation | |||
| 5 | Does the epidemiology (etiology and distribution) suggest an intentional release? | 1-3 | 1 – Epidemiology as expected |
| 2 – Epidemiology atypical but compatible with a naturally occurring disease | |||
| 3 – Very unusual epidemiology, possible intentional release | |||
| 6 | Is it a cluster of a disease targeted for elimination in Italy? | 1-3 | 1 – No/unknown[ |
| 2 – Possibly | |||
| 3 – Yes | |||
| 7 | Is the event occurring in vulnerable communities (Roma/Sinti communities, migrant populations, socio-economically vulnerable communities, etc) and/or susceptible communities (schools, prisons, cruise ships, etc)? | 1-3 | 1 – No/unknown[ |
| 2 – Possibly | |||
| 3 – Yes | |||
| 8 | Is the event describing an emerging disease, a re-emerging disease, or a disease at risk of importation in Italy? | 1-3 | 1 – No/unknown[ |
| 2 – Possibly | |||
| 3 – Yes | |||
| 9 | Is the event described possibly eligible, if validated, for notification under EWRS or IHR? Does it refer to a disease targeted for eradication? | 1-3 | 1 – No/unknown |
| 2 – Possibly | |||
| 3 – Yes | |||
| 10 | Does the event describe an outbreak close to an international border? | 1-3 | 1 – No/unknown |
| 2 – Possibly | |||
| 3 – Yes | |||
| 11 | Is the report from a trusted source? | 1-4 | 1 – Report from a potentially unreliable source |
| 2 – Report from a potentially reliable source (eg, NGO, news sources of good reputation) | |||
| 3 – Report from a reliable source (eg, WHO, national health authorities) | |||
| 4 – Validated event | |||
This value was used when the event does not indicate a disease case or outbreak but a risk (eg, white powder incident).
Figure 1.Information Flow Diagram
List of Pathogens, Illnesses, and Syndromes Selected as Priorities for Event-Based Surveillance During EXPO 2015
Invasive group A Strep Infection; leptospirosis; anthrax; HIV infection; arenavirus infection; rabies; SARS virus infection; smallpox; diphtheria; pneumococcal disease, and pertussis were also included in the priority list of diseases on the basis of the assessment conducted ahead of the London Olympics 2012.
Eight conditions were included under food- and waterborne illnesses: viral gastroenteritis, bacterial food intoxications, E. coli, Campylobacter, hepatitis A, Salmonella, Shigella, and other bacterial/viral food- and waterborne diseases.
Figure 2.Trend and Cyclical Pattern of the Items Filtered Daily by MedISys and Google Alerts
Figure 3.Number of Events Detected by Disease Group and Epiweek of Publication, April-November, 2015
Figure 4.Events Linked to the EBS Priority Event Meningococcal Meningitis, April-November 2015